{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:00:11Z","timestamp":1787932811442,"version":"build-2784847793"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Program of the National Natural Science Foundation of China","award":["No. 82370176"],"award-info":[{"award-number":["No. 82370176"]}]},{"name":"Key Program of the National Natural Science Foundation of China","award":["Grant No. 12331018"],"award-info":[{"award-number":["Grant No. 12331018"]}]},{"name":"Major Research Plan of Hubei Province of China","award":["Grant No. CZKYXM2023036JZ"],"award-info":[{"award-number":["Grant No. CZKYXM2023036JZ"]}]},{"name":"Major Research Plan of the National Natural Science Foundation of China","award":["Grant No. 92374108"],"award-info":[{"award-number":["Grant No. 92374108"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-026-00687-2","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T22:15:55Z","timestamp":1774390555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improving severity grading of chemotherapy-induced myelosuppression in AML via data-driven and model-based deep learning"],"prefix":"10.1038","volume":"12","author":[{"given":"Yu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfeng","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suoqin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"687_CR1","first-page":"149ra118","volume":"4","author":"M Jan","year":"2012","unstructured":"Jan, M. et al. Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci. Transl. Med. 4, 149ra118\u2013149ra118 (2012).","journal-title":"Sci. Transl. Med."},{"key":"687_CR2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1158\/1078-0432.CCR-21-2863","volume":"28","author":"K Venugopal","year":"2022","unstructured":"Venugopal, K. et al. Dnmt3a harboring leukemia-associated mutations directs sensitivity to DNA damage at replication forks. Clin. Cancer Res. 28, 756\u2013769 (2022).","journal-title":"Clin. Cancer Res."},{"key":"687_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-11-41","volume":"11","author":"N Rochet","year":"2011","unstructured":"Rochet, N. et al. Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III-the OVAR-IMRT-02 study. BMC Cancer 11, 1\u20137 (2011).","journal-title":"BMC Cancer"},{"key":"687_CR4","doi-asserted-by":"crossref","first-page":"e00507","DOI":"10.1002\/prp2.507","volume":"7","author":"H Wessels","year":"2019","unstructured":"Wessels, H. et al. Pharmacodynamics, safety, and immunogenicity of pelmeg\u00ae, a pegfilgrastim biosimilar in healthy subjects. Pharmacol. Res. Perspect. 7, e00507 (2019).","journal-title":"Pharmacol. Res. Perspect."},{"key":"687_CR5","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1007\/s12325-020-01419-6","volume":"37","author":"RS Epstein","year":"2020","unstructured":"Epstein, R. S. et al. Patient burden and real-world management of chemotherapy-induced myelosuppression: results from an online survey of patients with solid tumors. Adv. Ther. 37, 3606\u20133618 (2020).","journal-title":"Adv. Ther."},{"key":"687_CR6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.critrevonc.2009.03.004","volume":"72","author":"L Repetto","year":"2009","unstructured":"Repetto, L. et al. Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey. Crit. Rev. Oncol. Hematol. 72, 170\u2013179 (2009).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"687_CR7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","volume":"1","author":"AC Dueck","year":"2015","unstructured":"Dueck, A. C. et al. Validity and reliability of the Us National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). JAMA Oncol. 1, 1051\u20131059 (2015).","journal-title":"JAMA Oncol."},{"key":"687_CR8","doi-asserted-by":"crossref","first-page":"djv216","DOI":"10.1093\/jnci\/djv216","volume":"107","author":"G Thanarajasingam","year":"2015","unstructured":"Thanarajasingam, G., Hubbard, J. M., Sloan, J. A. & Grothey, A. The imperative for a new approach to toxicity analysis in oncology clinical trials. J. Natl. Cancer Inst. 107, djv216 (2015).","journal-title":"J. Natl. Cancer Inst."},{"key":"687_CR9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(16)00038-3","volume":"17","author":"G Thanarajasingam","year":"2016","unstructured":"Thanarajasingam, G. et al. Longitudinal adverse event assessment in oncology clinical trials: the toxicity over time (toxt) analysis of alliance trials ncctg n9741 and 979254. Lancet Oncol. 17, 663\u2013670 (2016).","journal-title":"Lancet Oncol."},{"key":"687_CR10","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/S2352-3026(18)30051-6","volume":"5","author":"G Thanarajasingam","year":"2018","unstructured":"Thanarajasingam, G. et al. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. Lancet Haematol. 5, e563\u2013e598 (2018).","journal-title":"Lancet Haematol."},{"key":"687_CR11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41568-025-00796-w","volume":"25","author":"C Harkos","year":"2025","unstructured":"Harkos, C. et al. Using mathematical modelling and ai to improve delivery and efficacy of therapies in cancer. Nat. Rev. Cancer 25, 324\u2013340 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"687_CR12","doi-asserted-by":"crossref","unstructured":"Reynolds, D. A. et al. Gaussian mixture models. In: Li, S. Z. & Jain, A. K. (eds) Encyclopedia of Biometrics. 741\u2013742 (Springer, Boston, MA, 2009).","DOI":"10.1007\/978-0-387-73003-5_196"},{"key":"687_CR13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1109\/5254.708428","volume":"13","author":"MA Hearst","year":"1998","unstructured":"Hearst, M. A., Dumais, S. T., Osuna, E., Platt, J. & Scholkopf, B. Support vector machines. IEEE Intell. Syst. Appl. 13, 18\u201328 (1998).","journal-title":"IEEE Intell. Syst. Appl."},{"key":"687_CR14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/323533a0","volume":"323","author":"DE Rumelhart","year":"1986","unstructured":"Rumelhart, D. E., Hinton, G. E. & Williams, R. J. Learning representations by back-propagating errors. Nature 323, 533\u2013536 (1986).","journal-title":"Nature"},{"key":"687_CR15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.2517-6161.1958.tb00292.x","volume":"20","author":"DR Cox","year":"1958","unstructured":"Cox, D. R. The regression analysis of binary sequences. J. R. Stat. Soc. Ser. B Stat. Methodol. 20, 215\u2013232 (1958).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"687_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"687_CR17","doi-asserted-by":"crossref","unstructured":"Chen, T. Xgboost: A Scalable Tree Boosting System (Cornell University, 2016).","DOI":"10.1145\/2939672.2939785"},{"key":"687_CR18","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/cbic.201100421","volume":"12","author":"R Schauer","year":"2011","unstructured":"Schauer, R. & Kamerling, J. P. Sialic acids in cancer biology and immunity. ChemBioChem 12, 2246\u20132264 (2011).","journal-title":"ChemBioChem"},{"key":"687_CR19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10719-008-9183-z","volume":"26","author":"A Varki","year":"2009","unstructured":"Varki, A. Multiple changes in sialic acid biology during human evolution. Glycoconj. J. 26, 231\u2013245 (2009).","journal-title":"Glycoconj. J."},{"key":"687_CR20","first-page":"1319","volume":"28","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Serum sialic acid level as a novel biomarker for disease activity in systemic lupus erythematosus. Lupus 28, 1319\u20131326 (2019).","journal-title":"Lupus"},{"key":"687_CR21","doi-asserted-by":"crossref","first-page":"e8502","DOI":"10.1097\/MD.0000000000008502","volume":"96","author":"X Zhou","year":"2017","unstructured":"Zhou, X., Sun, X. & Zhao, W. Prognostic value of lactate dehydrogenase in hematological malignancies. Medicine 96, e8502 (2017).","journal-title":"Medicine"},{"key":"687_CR22","first-page":"1","volume":"19","author":"D Liu","year":"2015","unstructured":"Liu, D. et al. Procalcitonin as a biomarker for severe sepsis and septic shock patients: a meta-analysis. Crit. Care 19, 1\u20139 (2015).","journal-title":"Crit. Care"},{"key":"687_CR23","first-page":"2020","volume":"2020","author":"K-W Wang","year":"2020","unstructured":"Wang, K.-W. et al. Coagulation parameters and risk of progressive hemorrhagic injury after traumatic brain injury: a systematic review and meta-analysis. BioMed. Res. Int. 2020, 2020 (2020).","journal-title":"BioMed. Res. Int."},{"key":"687_CR24","first-page":"47","volume":"4","author":"X-L Ye","year":"2016","unstructured":"Ye, X.-L., Zhang, J.-M. & Liu, H.-C. Serum amyloid a as a marker of disease activity and treatment response in acute leukemia. World J. Clin. Cases 4, 47 (2016).","journal-title":"World J. Clin. Cases"},{"key":"687_CR25","first-page":"5392","volume":"22","author":"R Ali","year":"2016","unstructured":"Ali, R. et al. Glucose metabolism in cancer and ischemia: possible therapeutic consequences of metabolic reprogramming. Curr. Pharm. Des. 22, 5392\u20135400 (2016).","journal-title":"Curr. Pharm. Des."},{"key":"687_CR26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston, N. R. & Ashworth, J. J. Role of c-reactive protein at sites of inflammation and infection. Front. Immunol. 9, 754 (2018).","journal-title":"Front. Immunol."},{"key":"687_CR27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/ndt\/gfn521","volume":"24","author":"S Okuno","year":"2009","unstructured":"Okuno, S. et al. Serum \u03b22-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients. Nephrol. Dial. Transplant. 24, 571\u2013577 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"687_CR28","first-page":"2335","volume":"9","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Globulin as a predictor for treatment-free survival in chronic myeloid leukemia. J. Cancer 9, 2335\u20132341 (2018).","journal-title":"J. Cancer"},{"key":"687_CR29","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ijsu.2013.07.014","volume":"11","author":"B Azab","year":"2013","unstructured":"Azab, B. et al. The prognostic value of the albumin\/globulin ratio in cancer patients. Int. J. Surg. 11, 882\u2013886 (2013).","journal-title":"Int. J. Surg."},{"key":"687_CR30","first-page":"1","volume":"13","author":"S Li","year":"2018","unstructured":"Li, S. et al. Albumin and neutrophil-lymphocyte ratio (nlr) predict survival in patients with pancreatic adenocarcinoma treated with sbrt. Radiat. Oncol. 13, 1\u20138 (2018).","journal-title":"Radiat. Oncol."},{"key":"687_CR31","first-page":"343","volume":"24","author":"X-H Yang","year":"2019","unstructured":"Yang, X.-H. et al. Cholinesterase and mortality risk in acute leukemia patients. Hematology 24, 343\u2013348 (2019).","journal-title":"Hematology"},{"key":"687_CR32","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/CIRCULATIONAHA.118.033783","volume":"137","author":"Z Chen","year":"2018","unstructured":"Chen, Z. et al. Complement factor b production in renal tubular cells and its role in sodium transporter expression. Circulation 137, 2423\u20132442 (2018).","journal-title":"Circulation"},{"key":"687_CR33","first-page":"227","volume":"51","author":"JH Park","year":"2016","unstructured":"Park, J. H. et al. Platelet to lymphocyte ratio as a prognostic indicator in patients with acute myeloid leukemia. Blood Res. 51, 227\u2013232 (2016).","journal-title":"Blood Res."},{"key":"687_CR34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/10408398.2011.651543","volume":"55","author":"R Batool","year":"2015","unstructured":"Batool, R., Butt, M. S., Sultan, M. T., Saeed, F. & Naz, R. Protein\u2013energy malnutrition: a risk factor for various ailments. Crit. Rev. Food Sci. Nutr. 55, 242\u2013253 (2015).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"687_CR35","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2016.66.9622","volume":"34","author":"RB Gerbing","year":"2016","unstructured":"Gerbing, R. B. et al. Shorter remission telomere length predicts delayed neutrophil recovery after acute myeloid leukemia therapy: a report from the children\u2019s oncology group. J. Clin. Oncol. 34, 3766\u20133772 (2016).","journal-title":"J. Clin. Oncol."},{"key":"687_CR36","first-page":"6679","volume":"35","author":"S\u00d6 Arik","year":"2021","unstructured":"Arik, S. \u00d6 & Pfister, T. Tabnet: attentive interpretable tabular learning. Proc. AAAI Conf. Artif. Intell. 35, 6679\u20136687 (2021).","journal-title":"Proc. AAAI Conf. Artif. Intell."},{"key":"687_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0962492900000015","volume":"9","author":"MD Buhmann","year":"2000","unstructured":"Buhmann, M. D. Radial basis functions. Acta Numer. 9, 1\u201338 (2000).","journal-title":"Acta Numer."},{"key":"687_CR38","doi-asserted-by":"crossref","unstructured":"Pezoulas, V. C. et al. Generation of virtual patient data for in-silico cardiomyopathies drug development using tree ensembles: a comparative study. In 2020 42nd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) (eds Akay, M., Weiland, J. & Spandidos, D. A.) 5343\u20135346 (IEEE, 2020).","DOI":"10.1109\/EMBC44109.2020.9176567"},{"key":"687_CR39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.compbiomed.2019.03.001","volume":"107","author":"VC Pezoulas","year":"2019","unstructured":"Pezoulas, V. C. et al. Medical data quality assessment: on the development of an automated framework for medical data curation. Comput. Biol. Med. 107, 270\u2013283 (2019).","journal-title":"Comput. Biol. Med."},{"key":"687_CR40","first-page":"90","volume":"118","author":"VC Pezoulas","year":"2019","unstructured":"Pezoulas, V. C. et al. Enhancing medical data quality through data curation: a case study in primary sj\u00f6gren\u2019s syndrome. Clin. Exp. Rheumatol. 118, 90\u201396 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"687_CR41","unstructured":"Robnik-Sikonja, M. semiArtificial: Generator of Semi-Artificial Data. R package version 2.4.1. https:\/\/CRAN.R-project.org\/package=semiArtificial (2021)."},{"key":"687_CR42","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1007\/s11095-015-1699-x","volume":"32","author":"D Teutonico","year":"2015","unstructured":"Teutonico, D. et al. Generating virtual patients by multivariate and discrete re-sampling techniques. Pharm. Res. 32, 3228\u20133237 (2015).","journal-title":"Pharm. Res."},{"key":"687_CR43","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1200\/JCO.2002.02.140","volume":"20","author":"LE Friberg","year":"2002","unstructured":"Friberg, L. E., Henningsson, A., Maas, H., Nguyen, L. & Karlsson, M. O. Model of chemotherapy-induced myelosuppression with parameter consistency across drugs. J. Clin. Oncol. 20, 4713\u20134721 (2002).","journal-title":"J. Clin. Oncol."},{"key":"687_CR44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1023573429626","volume":"21","author":"LE Friberg","year":"2003","unstructured":"Friberg, L. E. & Karlsson, M. O. Mechanistic models for myelosuppression. Investig. N. Drugs 21, 183\u2013194 (2003).","journal-title":"Investig. N. Drugs"},{"key":"687_CR45","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/cpt.1080","volume":"104","author":"C Fornari","year":"2018","unstructured":"Fornari, C. et al. Understanding hematological toxicities using mathematical modeling. Clin. Pharmacol. Ther. 104, 644\u2013654 (2018).","journal-title":"Clin. Pharmacol. Ther."},{"key":"687_CR46","doi-asserted-by":"crossref","unstructured":"Kennedy, J. & Eberhart, R. Particle swarm optimization. In Proceedings of ICNN\u201995\u2014International Conference on Neural Networks, Vol. 4 (eds Palaniswami, M., II, R. J. M., Fukuda, T. & deSilva, C.) 1942\u20131948 (IEEE, 1995).","DOI":"10.1109\/ICNN.1995.488968"},{"key":"687_CR47","first-page":"498","volume":"9","author":"C Fornari","year":"2020","unstructured":"Fornari, C., Pin, C., Yates, J. W., Mettetal, J. T. & Collins, T. A. Importance of stability analysis when using nonlinear semimechanistic models to describe drug-induced hematotoxicity. CPT: Pharmacomet. Syst. Pharmacol. 9, 498\u2013508 (2020).","journal-title":"CPT: Pharmacomet. Syst. Pharmacol."},{"key":"687_CR48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.chemolab.2015.08.020","volume":"149","author":"F Marini","year":"2015","unstructured":"Marini, F. & Walczak, B. Particle swarm optimization (pso). a tutorial. Chemometr. Intell. Lab. Syst. 149, 153\u2013165 (2015).","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"687_CR49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller, A. B. et al. Reporting results of cancer treatment. Cancer 47, 207\u2013214 (1981).","journal-title":"Cancer"},{"key":"687_CR50","first-page":"21","volume":"2","author":"NM Razali","year":"2011","unstructured":"Razali, N. M. et al. Power comparisons of Shapiro-Wilk, Kolmogorov-Smirnov, Lilliefors and Anderson-Darling tests. J. Stat. Model. Anal. 2, 21\u201333 (2011).","journal-title":"J. Stat. Model. Anal."},{"key":"687_CR51","unstructured":"McKnight, P. E. & Najab, J. Mann-Whitney U test. In: Weiner, I. B. & Craighead, W. E. (eds) The Corsini Encyclopedia of Psychology. (John Wiley & Sons, Hoboken, NJ, 2010)."},{"key":"687_CR52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1109\/79.543975","volume":"13","author":"TK Moon","year":"1996","unstructured":"Moon, T. K. The expectation-maximization algorithm. IEEE Signal Process. Mag. 13, 47\u201360 (1996).","journal-title":"IEEE Signal Process. Mag."},{"key":"687_CR53","first-page":"521","volume":"7","author":"M Berthold","year":"1994","unstructured":"Berthold, M. & Diamond, J. Boosting the performance of RBF networks with dynamic decay adjustment. Adv. Neural Inform Proc. Syst. 7, 521\u2013528 (1994).","journal-title":"Adv. Neural Inform Proc. Syst."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00687-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00687-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00687-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:35:04Z","timestamp":1780389304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-026-00687-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1038\/s41540-026-00687-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8109262\/v1","asserted-by":"object"}]},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"13 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}